API Endpoint for journals.

GET /api/articles/49089/?format=api
HTTP 200 OK
Allow: GET
Content-Type: application/json
Vary: Accept

{
    "pk": 49089,
    "title": "Antimuscarinic Toxicity Safely Managed with High-Dose Transdermal Rivastigmine: A Case Report",
    "subtitle": null,
    "abstract": "<p><strong>Introduction</strong>: Antimuscarinic toxicity, which can cause delirium and unsafe behavior, may result from an adverse effect of prescribed medications or from non-medical substance use. Physostigmine shortages have prompted use of transdermal rivastigmine for management of antimuscarinic toxicity; however, symptom control is equivocal at standard dosing.</p>\n<p><strong>Case Report: </strong>A patient with antimuscarinic toxicity was treated with physostigmine and transitioned to 26.6 milligrams/24 hours transdermal rivastigmine for sustained symptom control. He experienced no adverse effects and tolerated floor admission.</p>\n<p><strong>Discussion</strong>: There is mechanistic plausibility supporting safe, sustained control of antimuscarinic toxicity with high-dose transdermal rivastigmine. Central distribution is more rapid than serum distribution and higher doses correlate with a shorter time to peak concentration.</p>",
    "language": "eng",
    "license": {
        "name": "Creative Commons Attribution 4.0",
        "short_name": "CC BY 4.0",
        "text": "Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.\r\n\r\nNo additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.",
        "url": "https://creativecommons.org/licenses/by/4.0"
    },
    "keywords": [
        {
            "word": "drug overdose"
        },
        {
            "word": "Muscarinic Antagonists"
        },
        {
            "word": "Physostigmine"
        },
        {
            "word": "Rivastigmine"
        },
        {
            "word": "case report"
        }
    ],
    "section": "Case Reports",
    "is_remote": true,
    "remote_url": "https://escholarship.org/uc/item/0f10d1kc",
    "frozenauthors": [
        {
            "first_name": "Christopher",
            "middle_name": "James",
            "last_name": "Watson",
            "name_suffix": "",
            "institution": "Maine Medical Center, Department of Emergency Medicine, Portland, Maine; Northern New England Poison Center, Portland, Maine; Tufts University School of Medicine, Boston, Massachusetts",
            "department": ""
        },
        {
            "first_name": "Emilie",
            "middle_name": "M.",
            "last_name": "Burrill",
            "name_suffix": "",
            "institution": "Maine Medical Center, Department of Emergency Medicine, Portland, Maine; Maine Medical Center, Acute Care Pharmacy Services, Portland, Maine",
            "department": ""
        },
        {
            "first_name": "William",
            "middle_name": "S.",
            "last_name": "Jaffee",
            "name_suffix": "",
            "institution": "Tufts University School of Medicine, Boston, Massachusetts; Maine Medical Center, Adult Inpatient Medicine, Portland, Maine",
            "department": ""
        }
    ],
    "date_submitted": "2025-07-22T20:54:42.923000+01:00",
    "date_accepted": "2025-09-12T16:58:16.012000+01:00",
    "date_published": "2026-01-16T23:54:00Z",
    "render_galley": null,
    "galleys": [
        {
            "label": "PDF",
            "type": "pdf",
            "path": "https://journalpub.escholarship.org/uciem_cpcem/article/49089/galley/48092/download/"
        }
    ]
}